OTHER GROUP COMPANIES
market

Bliss GVS Pharma gets revision in credit ratings by Infomerics; Stock trades flat

The long-term bank facilities have been revised to IVR BBB/ Stable and short-term facilities to IVR A3+.

January 12, 2022 12:16 IST | India Infoline News Service
IT Stocks Up
Bliss GVS Pharma Limited's credit rating has been revised by Infomerics Valuation and Rating Private Limited with respect to the bank facilities of the company.

The long-term bank facilities Rs84.25cr (increased from Rs70cr) in Exim Bank and Federal Bank have been revised to IVR BBB/ Stable from IVR BBB- / Positive.

The credit rating agency also revised the company’s rating on short-term bank facilities Rs75cr (reduced from Rs90cr) in Federal Bank to IVR A3+ from IVR A3.

At around 12.20 PM, Bliss GVS Pharma Ltd was trading at Rs99.40 per share down by Rs0.05 or 0.05% from its previous closing of Rs99.45 per share on the BSE.

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity